Invesaro

Stocks ITW Financial statements

Financial statements

ILLINOIS TOOL WORKS INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ILLINOIS TOOL WORKS INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue13,59914,31414,76814,10912,57414,45515,93216,10715,89816,044
Cost of revenue7,9088,3068,6048,1877,3758,4898,1367,9447,6047,556
Gross profit5,6916,0086,1645,9225,1995,9667,7968,1638,2948,488
Research and development223225233221214239269284292302
Operating income3,0563,4853,5843,4022,8823,4773,7904,0404,2644,216
Interest expense237260257221206202203266283292
Interest income38453529171222514440
Other non-operating income89456710728512554944142
Pre-tax income2,9083,2703,3943,2882,7043,3263,8423,8232,6032,384
Income tax8731,583831767595632808866934900
Net income2,0351,6872,5632,5212,1092,6943,0342,9573,4883,066
EBITDA3,3023,7413,8563,6693,1553,7544,0664,3224,5654,533
EPS, basic5.734.907.657.786.668.559.809.7711.7510.52
EPS, diluted5.704.867.607.746.638.519.779.7411.7110.49
Shares, basic (weighted)355344335324317315310303297292
Shares, diluted (weighted)357347337326318316311304298292
Dividend per share2.402.863.564.144.424.725.065.425.806.22

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents2,4723,0941,5041,9812,5641,5277081,065948851
Receivables2,3572,6282,6222,4612,5062,8403,1713,1232,9913,227
Inventory1,0761,2201,3181,1641,1891,6942,0541,7071,6051,659
Other current assets122119127121119140175157147226
Total current assets6,1237,2785,7786,2536,5236,3746,2706,2355,8566,200
Property, plant and equipment1,6521,7781,7911,7291,7771,8091,8481,9762,0362,230
Lease right-of-use assets206216222212248266294
Goodwill4,5584,7524,6334,4924,6904,9654,8644,9094,8395,098
Intangible assets1,4631,2721,084851781972768657592591
Other non-current assets9561,1951,0301,2271,3081,4051,1781,2621,3751,510
Total assets15,20116,78014,87015,06815,61216,07715,42215,51815,06716,148
Accounts payable511590524472534585594581519522
Accrued liabilities1,2021,2581,2711,2171,2841,6481,7281,6631,5761,636
Short-term debt6528501,35143507781,5901,8251,5552,286
Total current liabilities2,7603,0533,5422,1542,5893,4704,4604,6754,3085,126
Long-term debt7,1777,4786,0297,7547,7726,9096,1736,3396,3086,683
Lease liabilities128133133131148158180
Other non-current liabilities8718828391,0001,0681,0539431,0141,015959
Total liabilities10,94212,19111,61212,03812,43012,45112,33312,50511,75012,922
Total debt7,8277,4797,3797,7588,1227,4776,7087,7007,0857,682
Paid-in capital1,1881,2181,2531,3041,3621,4321,5011,5881,6691,771
Retained earnings19,50520,21021,21722,40323,11424,32525,79927,12228,89330,150
Treasury stock-14,638-15,562-17,545-18,982-19,659-20,636-22,377-23,870-25,375-26,875
Other comprehensive income-1,807-1,287-1,677-1,705-1,642-1,502-1,841-1,834-1,877-1,827
Minority interests5444111111
Total equity4,2594,5893,2583,0303,1823,6263,0893,0133,3173,226
Total liabilities and equity15,20116,78014,87015,06815,61216,07715,42215,51815,06716,148
Shares outstanding347342328320317313305299294289

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income2,0351,6872,5632,5212,1092,6943,0342,9573,4883,066
Depreciation and amortization246256272267273277276282301317
Stock-based compensation39364041425363696169
Change in receivables-132-138-604095-240-4616434-92
Change in inventory9-81-1089843-450-45536017634
Cash from operations2,3022,4022,8112,9952,8072,5572,3483,5393,2813,126
Capital expenditures-273-297-364-326-236-296-412-455-437-419
Acquisitions-453-30-40-731-20-115-119
Sales and maturities of investments2143162014381227117
Cash from investing-532-251-325-183-214-984-110-403-144-521
Stock issued84842285665029535265
Share buybacks-2,000-1,000-2,000-1,500-706-1,000-1,750-1,500-1,500-1,500
Dividends paid-821-941-1,124-1,321-1,379-1,463-1,542-1,615-1,695-1,785
Cash from financing-2,255-1,674-3,964-2,326-2,049-2,564-3,000-2,782-3,189-2,744
Exchange rate effect-133145-112-939-46-573-6542
Net change in cash-618622-1,590477583-1,037-819357-117-97
Free cash flow2,0292,1052,4472,6692,5712,2611,9363,0842,8442,707
Interest paid212240247223194197199260248279
Income taxes paid9201,0188387425917319931,0261,1801,052

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $274.32 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin53.0%Gross profit / revenue.
Operating margin26.5%Operating income / revenue.
EBITDA margin28.5%EBITDA (operating income + depreciation and amortization) / revenue.
Net margin19.4%Net income / revenue.
FCF margin17.7%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin20.2%Cash from operations / revenue.
Return on assets (ROA)19.4%Net income / average total assets.
Stock-based pay / revenue0.4%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue2.5%Capital expenditures / revenue.
D&A / revenue2.0%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y0.9%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y0.2%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y5.0%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y2.3%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y2.9%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y10.3%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y-1.1%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y3.6%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y7.9%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y-0.7%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y3.7%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y7.5%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-12.1%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y0.4%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y7.8%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y-10.4%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y2.4%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y9.6%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-4.7%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y10.0%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y2.2%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-4.8%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y11.8%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y1.0%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y7.2%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y7.1%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y7.1%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y7.2%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y1.5%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y0.7%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-1.8%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-2.0%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-1.7%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.11xCurrent assets / current liabilities.
Quick ratio0.74x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.14x(Cash + short-term investments) / current liabilities.
Debt / assets39.7%Total debt / total assets.
Liabilities / assets82.4%Total liabilities / total assets.
Net debt$5.71BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA1.22xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage14.5xOperating income / interest expense.
Working capital$647.0MCurrent assets - current liabilities.
Goodwill and intangibles / assets34.1%(Goodwill + intangible assets) / total assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.00xRevenue / average total assets.
Fixed asset turnover7.37xRevenue / average property, plant and equipment.
Inventory turnover4.41xCost of revenue / average inventory.
Days inventory83 days365 x average inventory / cost of revenue.
Receivables turnover4.62xRevenue / average receivables.
Days sales outstanding79 days365 x average receivables / revenue.
Days payables30 days365 x average accounts payable / cost of revenue.
Cash conversion cycle132 daysDays inventory + days sales outstanding - days payables.
FCF conversion91.5%Free cash flow / net income, when net income is positive.
Capex / operating cash flow12.3%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$11.13Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$57.38Revenue / diluted weighted shares.
FCF per share$10.18Free cash flow / diluted weighted shares.
Operating cash flow per share$11.60Cash from operations / diluted weighted shares.
Cash per share$2.95(Cash + short-term investments) / shares outstanding.
Payout ratio57.4%Dividends paid / net income, when net income is positive.
Dividends / FCF62.8%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF64.2%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$78.13BShare price x shares outstanding.
Enterprise value$83.84BMarket cap + total debt - cash - short-term investments.
P/E24.5xMarket cap / net income. Only when net income is positive.
P/S4.74xMarket cap / revenue.
P/FCF26.7xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF23.5xMarket cap / cash from operations, when positive.
EV/Sales5.09xEnterprise value / revenue.
EV/EBIT19.2xEnterprise value / operating income, when both are positive.
EV/EBITDA17.9xEnterprise value / EBITDA, when both are positive.
EV/FCF28.7xEnterprise value / free cash flow, when both are positive.
FCF yield3.7%Free cash flow / market cap.
Earnings yield4.1%Net income / market cap (the inverse of P/E).
Dividend yield2.3%Dividends paid over the period / market cap.
Shareholder yield4.7%(Dividends paid + share buybacks) / market cap.
PEG10.2xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was ILLINOIS TOOL WORKS INC's revenue in fiscal 2025?

ILLINOIS TOOL WORKS INC reported revenue of $16.04B for fiscal 2025, 0.9% higher than the year before.

Was ILLINOIS TOOL WORKS INC profitable in fiscal 2025?

Yes. Net income was $3.07B, a net margin of 19.1%.

How much free cash flow did ILLINOIS TOOL WORKS INC generate in fiscal 2025?

Cash from operations of $3.13B minus capital expenditures of $419.0M left free cash flow of $2.71B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ILLINOIS TOOL WORKS INC